Fubotv (FUBO) had the highest return between January 20, 2018 and January 29, 2018 by a US stock, returning 203.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Fubotv (FUBO) | 1/20/2018 - 1/29/2018 | 203.92% |
Avalon GloboCare (ALBT) | 1/20/2018 - 1/29/2018 | 95.49% |
Atossa Genetics (ATOS) | 1/20/2018 - 1/29/2018 | 74.81% |
ProMIS Neurosciences (PMN) | 1/20/2018 - 1/29/2018 | 73.53% |
Sobr Safe (SOBR) | 1/20/2018 - 1/29/2018 | 71.19% |
Vyne Therapeutics (VYNE) | 1/20/2018 - 1/29/2018 | 62.88% |
Adverum Biotechnologies (ADVM) | 1/20/2018 - 1/29/2018 | 54.08% |
Applied Digital (APLD) | 1/20/2018 - 1/29/2018 | 50.85% |
Rocket Pharmaceuticals (RCKT) | 1/20/2018 - 1/29/2018 | 43.24% |
Crispr Therapeutics (CRSP) | 1/20/2018 - 1/29/2018 | 43.19% |
Can Fite Biopharma Ltd ADR (CANF) | 1/20/2018 - 1/29/2018 | 42.94% |
Kazia Therapeutics Ltd ADR (KZIA) | 1/20/2018 - 1/29/2018 | 38.51% |
Renovaro Biosciences (RENB) | 1/20/2018 - 1/29/2018 | 37.66% |
Quantum Computing (QUBT) | 1/20/2018 - 1/29/2018 | 36.84% |
vTv Therapeutics (VTVT) | 1/20/2018 - 1/29/2018 | 35.92% |
Intellia Therapeutics (NTLA) | 1/20/2018 - 1/29/2018 | 34.72% |
Myomo (MYO) | 1/20/2018 - 1/29/2018 | 33.52% |
Carisma Therapeutics (CARM) | 1/20/2018 - 1/29/2018 | 33.37% |
POET Technologies (POET) | 1/20/2018 - 1/29/2018 | 33.33% |
Redhill Biopharma (RDHL) | 1/20/2018 - 1/29/2018 | 31.95% |
World Acceptance (WRLD) | 1/20/2018 - 1/29/2018 | 31.81% |
Editas Medicine (EDIT) | 1/20/2018 - 1/29/2018 | 31.8% |
Immersion (IMMR) | 1/20/2018 - 1/29/2018 | 31.75% |
Zynex (ZYXI) | 1/20/2018 - 1/29/2018 | 29.64% |
Armata Pharmaceuticals (ARMP) | 1/20/2018 - 1/29/2018 | 29.13% |
